Chiang Yuting, Hosseinian Leila, Rhee Amanda, Itagaki Shinobu, Cavallaro Paul, Chikwe Joanna
Department of Cardiothoracic Surgery, The Mount Sinai Medical Center, New York, New York.
Department of Anesthesiology, The Mount Sinai Medical Center, New York, New York.
J Cardiothorac Vasc Anesth. 2015 Feb;29(1):76-81. doi: 10.1053/j.jvca.2014.07.017.
The aim of this study was to determine the effect of pulmonary artery catheterization on clinical outcomes after cardiac surgery in higher-risk patients.
Retrospective national database analysis.
U.S. hospitals.
A weighted sample of 2,063,337 patients undergoing cardiac surgery identified from the Nationwide Inpatient Sample (NIS) from January 1, 2000 to December 31, 2010.
Pulmonary artery catheterization.
Compared to patients who did not receive a pulmonary artery catheter, those who did on the whole were on average slightly older (66.6±11.9 years v 65.5±12.8 years, p<0.001), more likely to have pulmonary hypertension (7.5% v 5.1%, p<0.001), chronic obstructive pulmonary disease (24.6% v 20.7%, p<0.001), obesity (15.0% v 13.1%, p<0.001), and chronic renal failure (10.9% v 9.2%, p<0.001). In multivariate analysis, the risk of operative mortality in patients who underwent pulmonary artery catheterization was significantly higher than in those who did not (4.6% v 3.1%, p<0.001), adjusted OR 1.34 (95% CI 1.26-1.43, p<0.001). In propensity matched subgroup analysis operative mortality risk was higher in octogenarian patients (OR 1.24, p = 0.24), and patients with congestive heart failure (OR 1.39, p = 0.023) who underwent pulmonary artery catheterization. No significant difference in operative mortality was observed in low-risk patients according to whether or not they underwent pulmonary artery catheterization. The incidence of prolonged mechanical ventilation and length of stay>30 days was higher in patients who underwent pulmonary artery catheterization in all subgroups.
In contemporary practice pulmonary artery catheters do not appear to be associated with reductions in operative mortality or morbidity and are associated with increases in duration of ventilation and length of stay in the intensive care unit.
本研究旨在确定肺动脉导管插入术对高危患者心脏手术后临床结局的影响。
全国性数据库回顾性分析。
美国医院。
从2000年1月1日至2010年12月31日的全国住院患者样本(NIS)中确定的2,063,337例接受心脏手术患者的加权样本。
肺动脉导管插入术。
与未接受肺动脉导管的患者相比,接受该导管的患者总体上平均年龄稍大(66.6±11.9岁对65.5±12.8岁,p<0.001),更有可能患有肺动脉高压(7.5%对5.1%,p<0.001)、慢性阻塞性肺疾病(24.6%对20.7%,p<0.001)、肥胖症(15.0%对13.1%,p<0.001)和慢性肾衰竭(10.9%对9.2%,p<0.001)。在多变量分析中,接受肺动脉导管插入术的患者手术死亡率风险显著高于未接受者(4.6%对3.1%,p<0.001),校正后的比值比为1.34(95%置信区间1.26 - 1.43,p<0.001)。在倾向匹配亚组分析中,接受肺动脉导管插入术的八旬老人(比值比1.24,p = 0.24)和充血性心力衰竭患者(比值比1.39,p = 0.023)手术死亡风险更高。根据是否接受肺动脉导管插入术,低风险患者的手术死亡率无显著差异。在所有亚组中,接受肺动脉导管插入术的患者机械通气时间延长和住院时间>30天的发生率更高。
在当代实践中,肺动脉导管似乎与手术死亡率或发病率的降低无关,且与重症监护病房通气时间延长和住院时间增加有关。